With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union agency EDCTP approved for funding another new project: “LiberHetica: increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes …”. A great team lead by Liberian institutional rapresentatives made this come true, therefore I would like to thank Dr. Bolay Fotorma, Jemee Tegli, Dr. Stephen B. Kennedy, Gloria Mason, and Cecilia Morris.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

AfriNEXT

AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out

What if tropical diseases had as much attention as COVID?

In this article published by Nature, Prof. Francine Ntoumi addresses how the efforts to tackle Covid-19 are consequently and tragically neglecting all other diseases, for which it is estimated that